Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Ovarian Neoplasms

  Free Subscription


24.08.2026

1 Am J Surg Pathol
1 Br J Cancer
1 Eur J Obstet Gynecol Reprod Biol
2 Gynecol Oncol
1 Int J Cancer
2 Obstet Gynecol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Surg Pathol

  1. SMITH C, Dudley J, Savage J, Van de Vijver K, et al
    Ovarian Mucinous Neoplasms Associated With Mesonephric-like Lesions: An Updated Study With Novel Pathologic Features.
    Am J Surg Pathol. 2026 May 27. doi: 10.1097/PAS.0000000000002573.
    PubMed         Abstract available


    Br J Cancer

  2. LI X, Janik T, Mobs M, Florian S, et al
    Spatial, temporal, and molecular heterogeneity of ADC targets in high-grade serous ovarian carcinoma.
    Br J Cancer. 2026 Jun 2. doi: 10.1038/s41416-026-03482.
    PubMed         Abstract available


    Eur J Obstet Gynecol Reprod Biol

  3. CANDOTTI G, Spotorno V, Bergamini A, Bocciolone L, et al
    When less is more: perioperative and oncological outcomes of avoiding hysterectomy in selected patients with early-stage epithelial ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2026;326:115378.
    PubMed         Abstract available


    Gynecol Oncol

  4. WESTIN SN, Belotte J, Felicetti B, Aghera V, et al
    Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.
    Gynecol Oncol. 2026;212:173-180.
    PubMed         Abstract available

  5. AINIO C, Caruso G, Alessi S, Aiello AA, et al
    Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?
    Gynecol Oncol. 2026;212:145-151.
    PubMed         Abstract available


    Int J Cancer

  6. XING M, Zhou C, Tang Y, Xu S, et al
    Cross-Regulation Between DNA Methylation and Circadian Clock Reprogramming in Ovarian Cancer: Mechanistic Insights, Biomarker Potential, and Therapeutic Implications.
    Int J Cancer. 2026 Aug 19. doi: 10.1002/ijc.70704.
    PubMed         Abstract available


    Obstet Gynecol

  7. WRIGHT JD
    Primary Prevention of Ovarian Cancer With Salpingectomy: The Time is Now!
    Obstet Gynecol. 2026 Aug 20. doi: 10.1097/AOG.0000000000006421.
    PubMed        


  8. Salpingectomy for the Prevention of Epithelial Ovarian Cancer.
    Obstet Gynecol. 2026 Aug 20. doi: 10.1097/AOG.0000000000006400.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum